Influenza -Like Illness
16
2
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.4% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 9 completed trials
Clinical Trials (16)
Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France
Preventing Respiratory Viral Illness Invisibly
Seasonal Influenza Vaccine Effectiveness Study in Kenya
InfluenCEF Study: Study on the Headache Associated With Influenza Infection
Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness
Recombinant Influenza Vaccination in U.S. Nursing Homes
Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW)
Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal
COVID-19 Pandemic Response Network
Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals
Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
Home Testing of Respiratory Illness
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice